Education
About Us
Working with TipRanks
Follow Us
Foundation Fighting Blindness Retinal Degeneration Insider Profile
4 Followers
Foundation Fighting Blindness Retinal Degeneration, Director, See Remarks, Ten Percent Owner at Opus Genetics, holds 9.49M shares in Opus Genetics (Ticker: IRD).
Foundation Fighting Blindness Retinal Degeneration Opus Genetics (IRD)Director, See Remarks, Ten Percent Owner
Opus Genetics (IRD)
Director, See Remarks, Ten Percent Owner
Not Ranked
Foundation Fighting Blindness Retinal Degeneration has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Foundation Fighting Blindness Retinal Degeneration's holdings
Insider Roles
Director, See Remarks, Ten Percent Owner
Roles that Foundation Fighting Blindness Retinal Degeneration holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Foundation Fighting Blindness Retinal Degeneration
Foundation Fighting Blindness Retinal Degeneration's Trading History
List of latest transactions for each holding click on a transaction to see Foundation Fighting Blindness Retinal Degeneration's performance on stock
You May Also Like
Foundation Fighting Blindness Retinal Degeneration insider profile FAQ
What is the percentage of profitable transactions made by Foundation Fighting Blindness Retinal Degeneration?
The percentage of profitable transactions made by Foundation Fighting Blindness Retinal Degeneration is ―.
What is the average return per transaction made by Foundation Fighting Blindness Retinal Degeneration?
The average return per transaction made by Foundation Fighting Blindness Retinal Degeneration is ―.
What stocks does Foundation Fighting Blindness Retinal Degeneration hold?
Foundation Fighting Blindness Retinal Degeneration holds: IRD stocks.
What was Foundation Fighting Blindness Retinal Degeneration’s latest transaction?
Foundation Fighting Blindness Retinal Degeneration latest transaction was an Uninformative Buy of ―.
What was Foundation Fighting Blindness Retinal Degeneration's most profitable transaction?
Foundation Fighting Blindness Retinal Degeneration’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Foundation Fighting Blindness Retinal Degeneration's role in Opus Genetics?
Foundation Fighting Blindness Retinal Degeneration's role in Opus Genetics is Director, See Remarks, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.